Literature DB >> 2820989

The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage.

P Mayeux1, C Billat, R Jacquot.   

Abstract

Commercially available 125I-labeled erythropoietin, obtained by genetic engineering from a human gene, was used to characterize receptors for this hormone on the cell surface of rat erythroid progenitor cells. A low number of high affinity binding sites (487 +/- 32 sites/cell, Kd = 167 +/- 14 pm) were found. Nonerythroid cells and erythrocytes did not exhibit specific binding. The high affinity binding was reversible and displaced by unlabeled erythropoietin, but not by other hormones and growth factors. After incubation at 37 degrees C, nearly 35% of the specifically bound erythropoietin seemed to be internalized, as judged by resistance to acidic buffer treatment. Thus, binding showed characteristics of a hormone-receptor association. 125I-Erythropoietin-labeled cells were treated with the bifunctional reagent dissucinimidyl suberate. Analysis of the cellular extracts by polyacrylamide gel electrophoresis under denaturing and reducing conditions revealed that erythropoietin can be cross-linked to two molecules of 94 and 78 kDa, respectively. Both labeled bands disappeared when the cells were labeled in the presence of an excess of unlabeled erythropoietin. Under nonreducing conditions, a cross-linked band of 230-255 kDa was observed. The relationships between these bands are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820989

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Population pharmacokinetic and pharmacodynamic model-based comparability assessment of a recombinant human Epoetin Alfa and the Biosimilar HX575.

Authors:  Xiaoyu Yan; Philip J Lowe; Martin Fink; Alexander Berghout; Sigrid Balser; Wojciech Krzyzanski
Journal:  J Clin Pharmacol       Date:  2011-12-12       Impact factor: 3.126

Review 2.  Erythropoietin receptor. Subunit structure and activation.

Authors:  A D D'Andrea; L I Zon
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.

Authors:  V C Broudy; N Lin; J Egrie; C de Haën; T Weiss; T Papayannopoulou; J W Adamson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

4.  The role of the near upstream sequence in hypoxia-induced expression of the erythropoietin gene.

Authors:  M Gupta; E Goldwasser
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

5.  Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines.

Authors:  S Crotta; S Nicolis; A Ronchi; S Ottolenghi; L Ruzzi; Y Shimada; A R Migliaccio; G Migliaccio
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

6.  Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation.

Authors:  S Gobert; S Chretien; F Gouilleux; O Muller; C Pallard; I Dusanter-Fourt; B Groner; C Lacombe; S Gisselbrecht; P Mayeux
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

7.  Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.

Authors:  M T Mitjavila; J P Le Couedic; N Casadevall; S Navarro; J L Villeval; A Dubart; W Vainchenker
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Erythropoietin and interleukin-2 activate distinct JAK kinase family members.

Authors:  D L Barber; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.

Authors:  A Yoshimura; H F Lodish
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

10.  The effect of erythropoietin on normal and neoplastic cells.

Authors:  Steve Elliott; Angus M Sinclair
Journal:  Biologics       Date:  2012-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.